SARS-CoV 2
132
2
4
73
Key Insights
Highlights
Success Rate
82% trial completion
Published Results
17 trials with published results (13%)
Research Maturity
73 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.1%
16 terminated out of 132 trials
82.0%
-4.5% vs benchmark
8%
10 trials in Phase 3/4
23%
17 of 73 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 73 completed trials
Clinical Trials (132)
Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort
Exploring Brain Damages After COVID-19 Infection
COVID-19 Biorepository
Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19
Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections
Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry
Kidney in Coronavirus Disease 2019 Registry
Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)
GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)
COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children
Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations
Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
Convalescent Plasma for Early Treatment of COVID-19
Serological Testing for COVID-19 (SARS-CoV-2) in ESKD
Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling
Efficacy and Safety of COVID-19 Convalescent Plasma